Endologix named as Orange County's Outstanding Company in Medical Technology

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jun 5 2010Endologix, Inc.

Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA.  

John McDermott, President and CEO, said, "It is an honor to receive this award from TechAmerica. It is a testament to the hard work of all our employees and their dedication to our mission to be the leading innovator of treatments for aortic disorders. In the years ahead, we expect to introduce additional new technologies that will further improve patient outcomes and increase the adoption of our growing portfolio of aortic devices."

Source:

Endologix, Inc.

Posted in: Device / Technology News

Tags: , ,

Comments (0)

Suggested Reading

New study reveals lifestyle factors boosting IVF success
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates
Mapping the Microbiome: Dr. Abidemi Junaid on the Groundbreaking Vagina Chip
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations
Personality dictates binge-watching: Study reveals why we can't stop streaming
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses
Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking